119 related articles for article (PubMed ID: 1532615)
21. A comparison of ampicillin, erythromycin and erythromycin with sulphametopyrazine in the treatment of infective exacerbations of chronic bronchitis.
Willey RF; Gould JC; Grant IW
Br J Dis Chest; 1978 Jan; 72(1):13-20. PubMed ID: 341951
[TBL] [Abstract][Full Text] [Related]
22. Comparative study of dirithromycin and azithromycin in the treatment of acute bacterial exacerbations of chronic bronchitis.
Cazzola M; Vinciguerra A; Di Perna F; Califano C; Calderaro F; Salzillo A; Centanni S
J Chemother; 1999 Apr; 11(2):119-25. PubMed ID: 10326742
[TBL] [Abstract][Full Text] [Related]
23. A comparative safety and efficacy study of clarithromycin and erythromycin stearate in community-acquired pneumonia.
Anderson G; Esmonde TS; Coles S; Macklin J; Carnegie C
J Antimicrob Chemother; 1991 Feb; 27 Suppl A():117-24. PubMed ID: 1827098
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of clarithromycin compared to cefixime as outpatient treatment of lower respiratory tract infections.
Neu HC; Chick TW
Chest; 1993 Nov; 104(5):1393-9. PubMed ID: 8222794
[TBL] [Abstract][Full Text] [Related]
25. Clinical efficacy of dirithromycin versus miocamycin in the treatment of acute bronchitis or acute exacerbations of chronic bronchitis.
Pozzi E
J Antimicrob Chemother; 1993 Mar; 31 Suppl C():153-8. PubMed ID: 8478306
[TBL] [Abstract][Full Text] [Related]
26. Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of patients with acute exacerbation of chronic bronchitis.
Adler JL; Jannetti W; Schneider D; Zhang J; Palmer R; Notario G
Clin Ther; 2000 Dec; 22(12):1410-20. PubMed ID: 11192133
[TBL] [Abstract][Full Text] [Related]
27. Treating acute bacterial exacerbations of chronic bronchitis in patients unresponsive to previous therapy: sparfloxacin versus clarithromycin.
Lipsky BA; Unowsky J; Zhang H; Townsend L; Talbot GH
Clin Ther; 1999 Jun; 21(6):954-65. PubMed ID: 10440620
[TBL] [Abstract][Full Text] [Related]
28. Clarithromycin in the treatment of community-acquired lower respiratory tract infections.
Anderson G
J Hosp Infect; 1991 Sep; 19 Suppl A():21-7. PubMed ID: 1684979
[TBL] [Abstract][Full Text] [Related]
29. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
DeAbate CA; Mathew CP; Warner JH; Heyd A; Church D
Respir Med; 2000 Nov; 94(11):1029-37. PubMed ID: 11127487
[TBL] [Abstract][Full Text] [Related]
30. Cefaclor AF vs Clarithromycin in acute exacerbation of chronic bronchitis (B3M-PK-AJBG).
Khan S; Javaid A; Ghori RA; Mahmood K; Anwer N; Khan SU; Iqbal ZH; Rahman F; Ullah S; Imran K; Akhter N; Khan MK; Siddqui SJ; Fareed A; Khan MH
J Pak Med Assoc; 2003 Aug; 53(8):338-45. PubMed ID: 14558738
[TBL] [Abstract][Full Text] [Related]
31. Five-day dirithromycin therapy is as effective as seven-day erythromycin therapy for acute exacerbations of chronic bronchitis.
Wasilewski MM; Johns D; Sides GD
J Antimicrob Chemother; 1999 Apr; 43(4):541-8. PubMed ID: 10350384
[TBL] [Abstract][Full Text] [Related]
32. Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis.
DeAbate CA; Bettis R; Munk ZM; Fleming H; Munn NJ; Riffer E; Bagby B; Giguere G; Collins JJ
Clin Ther; 1999 Jan; 21(1):172-88. PubMed ID: 10090434
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and tolerance of erythromycin acistrate in the treatment of acute exacerbations of chronic bronchitis in the elderly.
Forsén KO; Wikberg R; Lehtonen L
Chemotherapy; 1993; 39(6):443-52. PubMed ID: 8222874
[TBL] [Abstract][Full Text] [Related]
34. The comparative efficacy and safety of clarithromycin and amoxycillin in the treatment of outpatients with acute maxillary sinusitis.
Karma P; Pukander J; Penttilä M; Ylikoski J; Savolainen S; Olén L; Melén I; Löth S
J Antimicrob Chemother; 1991 Feb; 27 Suppl A():83-90. PubMed ID: 1827106
[TBL] [Abstract][Full Text] [Related]
35. Safety and efficacy of lomefloxacin versus cefaclor in the treatment of acute exacerbations of chronic bronchitis.
Gotfried MH; Ellison WT
Am J Med; 1992 Apr; 92(4A):108S-113S. PubMed ID: 1316059
[TBL] [Abstract][Full Text] [Related]
36. Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential.
Peters DH; Clissold SP
Drugs; 1992 Jul; 44(1):117-64. PubMed ID: 1379907
[TBL] [Abstract][Full Text] [Related]
37. Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia.
Tellier G; Niederman MS; Nusrat R; Patel M; Lavin B
J Antimicrob Chemother; 2004 Aug; 54(2):515-23. PubMed ID: 15269191
[TBL] [Abstract][Full Text] [Related]
38. Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group.
DeAbate CA; Henry D; Bensch G; Jubran A; Chodosh S; Harper L; Tipping D; Talbot GH
Chest; 1998 Jul; 114(1):120-30. PubMed ID: 9674458
[TBL] [Abstract][Full Text] [Related]
39. Simplified treatment of acute lower respiratory tract infection with azithromycin: a comparison with erythromycin and amoxycillin. European Azithromycin Study Group.
Daniel R
J Int Med Res; 1991; 19(5):373-83. PubMed ID: 1660824
[TBL] [Abstract][Full Text] [Related]
40. Five days of cefprozil versus 10 days of clarithromycin in the treatment of an acute exacerbation of chronic bronchitis.
McCarty JM; Pierce PF
Ann Allergy Asthma Immunol; 2001 Oct; 87(4):327-34. PubMed ID: 11686426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
